Urologists key to informing patients of tobacco-bladder cancer link

This article originally appeared here.
Urologist Key to Patient Grasp of Tobacco-Bladder Cancer Link
Urologist Key to Patient Grasp of Tobacco-Bladder Cancer Link

(HealthDay News) -- For patients with bladder cancer, smoking status and primary source of information correlate with awareness of the harms of tobacco use, according to a study published online Nov. 10 in Cancer.

Jeffrey C. Basset, M.D., M.P.H., from the University of California in Los Angeles, and colleagues surveyed a stratified, random sample of bladder cancer survivors about tobacco use, risk factors, and sources of information on the causes of bladder cancer. Seven hundred ninety eligible participants completed the survey.

Of the cohort, 68 percent had a history of tobacco use and 19 percent were active smokers at baseline. The researchers found that the most cited risk factor for bladder cancer was tobacco use, with active smokers more knowledgeable than former or never smokers (90 versus 64 and 61 percent, respectively; P < 0.001). The predominant source of information was urologists, with active smokers most often citing them (82 percent). Compared with never smokers, active smokers had 6.37-fold higher odds of endorsing tobacco use as a risk factor for bladder cancer, in multivariate analyses. Smokers who cited their urologist as their information source had 2.80-fold higher odds of believing their cancer was caused by tobacco use.

"Urologists play a critical role in ensuring patients' knowledge of the connection between smoking and bladder cancer, particularly for active smokers who may be motivated to quit," the authors write.

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs